Lincoln Pharmaceuticals Begins Trial Run of New Manufacturing Unit in Gujarat, India

MT Newswires Live

2025/07/02

Lincoln Pharmaceuticals (NSE:LINCOLN, BOM:531633) has begun the trial run of a new manufacturing facility at Gandhinagar in Gujarat, India, according to a Wednesday filing to the Indian stock exchanges.

The new facility is expected to begin commercial production of active pharmaceutical ingredients in one to two years, subject to additional product permission received from the Food and Drugs Control Administration.

The facility has been set up with an investment of 40 million Indian rupees and will lead to a proposed capacity addition of 1.2 tons per annum.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2548850996"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2548850996\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2548850996?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-07-02 14:58","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2548850996","market":"sg","top_or_hot":-1,"title":"Lincoln Pharmaceuticals Begins Trial Run of New Manufacturing Unit in Gujarat, India","media":"MT Newswires Live","content":"<html><body><p> Lincoln Pharmaceuticals (NSE:LINCOLN, BOM:531633) has begun the trial run of a new manufacturing facility at Gandhinagar in Gujarat, India, according to a Wednesday filing to the Indian stock exchanges.</p><p>The new facility is expected to begin commercial production of active pharmaceutical ingredients in one to two years, subject to additional product permission received from the Food and Drugs Control Administration.</p><p>The facility has been set up with an investment of 40 million Indian rupees and will lead to a proposed capacity addition of 1.2 tons per annum.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lincoln Pharmaceuticals Begins Trial Run of New Manufacturing Unit in Gujarat, India</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLincoln Pharmaceuticals Begins Trial Run of New Manufacturing Unit in Gujarat, India\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-07-02 14:58</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Lincoln Pharmaceuticals (NSE:LINCOLN, BOM:531633) has begun the trial run of a new manufacturing facility at Gandhinagar in Gujarat, India, according to a Wednesday filing to the Indian stock exchanges.</p><p>The new facility is expected to begin commercial production of active pharmaceutical ingredients in one to two years, subject to additional product permission received from the Food and Drugs Control Administration.</p><p>The facility has been set up with an investment of 40 million Indian rupees and will lead to a proposed capacity addition of 1.2 tons per annum.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"FT_SY_MND","symbol_name":"MSCI 印度（美元）指数","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2548850996","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2548850996","pubTimestamp":1751439492,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Lincoln Pharmaceuticals  has begun the trial run of a new manufacturing facility at Gandhinagar in Gujarat, India, according to a Wednesday filing to the Indian stock exchanges.The new facility is expected to begin commercial production of active pharmaceutical ingredients in one to two years, subject to additional product permission received from the Food and Drugs Control Administration.The facility has been set up with an investment of 40 million Indian rupees and will lead to a proposed capacity addition of 1.2 tons per annum.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"LU0757428866.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AE\" (USD) ACC","LU1815336091.USD":"THREADNEEDLE (LUX) GLOBAL SMALLER COMPANIES \"AUP\" (USD) INC","BK4161":"工业机械","LECO":"林肯电气控股"},"translate_title":"林肯制药公司开始在印度古吉拉特邦试运行新生产装置","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNDmain":1,"LECO":1},"content_text":"Lincoln Pharmaceuticals (NSE:LINCOLN, BOM:531633) has begun the trial run of a new manufacturing facility at Gandhinagar in Gujarat, India, according to a Wednesday filing to the Indian stock exchanges.The new facility is expected to begin commercial production of active pharmaceutical ingredients in one to two years, subject to additional product permission received from the Food and Drugs Control Administration.The facility has been set up with an investment of 40 million Indian rupees and will lead to a proposed capacity addition of 1.2 tons per annum.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}